These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31135071)

  • 21. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
    Ulrichts H; Udvardy M; Lenting PJ; Pareyn I; Vandeputte N; Vanhoorelbeke K; Deckmyn H
    J Biol Chem; 2006 Feb; 281(8):4699-707. PubMed ID: 16373331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
    Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
    Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
    Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
    J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of binding characteristics between von Willebrand factor and platelet glycoprotein Ibα with various mutations by molecular dynamic simulation.
    Goto S; Oka H; Ayabe K; Yabushita H; Nakayama M; Hasebe T; Yokota H; Takagi S; Sano M; Tomita A; Goto S
    Thromb Res; 2019 Dec; 184():129-135. PubMed ID: 31739151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Force-induced on-rate switching and modulation by mutations in gain-of-function von Willebrand diseases.
    Kim J; Hudson NE; Springer TA
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4648-53. PubMed ID: 25810255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational Constraints on Local Unfolding Inhibit the Rheological Adaptation of von Willebrand Factor.
    Tischer A; Campbell JC; Machha VR; Moon-Tasson L; Benson LM; Sankaran B; Kim C; Auton M
    J Biol Chem; 2016 Feb; 291(8):3848-59. PubMed ID: 26677223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain.
    Cruz MA; Diacovo TG; Emsley J; Liddington R; Handin RI
    J Biol Chem; 2000 Jun; 275(25):19098-105. PubMed ID: 10764791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
    Nishio K; Anderson PJ; Zheng XL; Sadler JE
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function relationship of the A1 domain of von Willebrand factor.
    Girma JP; Ribba AS; Meyer D
    Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha.
    Vasudevan S; Roberts JR; McClintock RA; Dent JA; Celikel R; Ware J; Varughese KI; Ruggeri ZM
    J Biol Chem; 2000 Apr; 275(17):12763-8. PubMed ID: 10777573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-type von Willebrand disease: Local disorder of the platelet GPIbα β-switch drives high-affinity binding to von Willebrand factor.
    Tischer A; Machha VR; Moon-Tasson L; Auton M
    J Thromb Haemost; 2019 Dec; 17(12):2022-2034. PubMed ID: 31448872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the kinetic interplay between GPIbα-VWF binding interfaces to regulate hemostasis and thrombosis.
    Chen J; Zhou H; Diacovo A; Zheng XL; Emsley J; Diacovo TG
    Blood; 2014 Dec; 124(25):3799-807. PubMed ID: 25293780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Von Willebrand Factor A1-Collagen III Interaction Is Independent of Conformation and Type 2 Von Willebrand Disease Phenotype.
    Machha VR; Tischer A; Moon-Tasson L; Auton M
    J Mol Biol; 2017 Jan; 429(1):32-47. PubMed ID: 27889474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactions.
    Aponte-Santamaría C; Huck V; Posch S; Bronowska AK; Grässle S; Brehm MA; Obser T; Schneppenheim R; Hinterdorfer P; Schneider SW; Baldauf C; Gräter F
    Biophys J; 2015 May; 108(9):2312-21. PubMed ID: 25954888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress.
    Auton M; Sowa KE; Smith SM; Sedlák E; Vijayan KV; Cruz MA
    J Biol Chem; 2010 Jul; 285(30):22831-9. PubMed ID: 20498367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain.
    Legan ER; Liu Y; Arce NA; Parker ET; Lollar P; Zhang XF; Li R
    Blood; 2023 Mar; 141(10):1221-1232. PubMed ID: 36580664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha.
    Miyata S; Goto S; Federici AB; Ware J; Ruggeri ZM
    J Biol Chem; 1996 Apr; 271(15):9046-53. PubMed ID: 8621553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force Microscopy.
    Tobimatsu H; Nishibuchi Y; Sudo R; Goto S; Tanishita K
    J Atheroscler Thromb; 2015; 22(10):1091-9. PubMed ID: 25972025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.